WO1992018048A1 - Procede et installation de dialyse peritoneale - Google Patents
Procede et installation de dialyse peritoneale Download PDFInfo
- Publication number
- WO1992018048A1 WO1992018048A1 PCT/RU1992/000080 RU9200080W WO9218048A1 WO 1992018048 A1 WO1992018048 A1 WO 1992018048A1 RU 9200080 W RU9200080 W RU 9200080W WO 9218048 A1 WO9218048 A1 WO 9218048A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- unit
- dialysis
- solution
- units
- patient
- Prior art date
Links
- 238000000502 dialysis Methods 0.000 title claims abstract description 64
- 238000000034 method Methods 0.000 title claims abstract description 32
- 238000009434 installation Methods 0.000 title claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000004202 carbamide Substances 0.000 claims abstract description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 7
- 230000007423 decrease Effects 0.000 claims abstract description 7
- 239000008103 glucose Substances 0.000 claims abstract description 7
- 238000005406 washing Methods 0.000 claims abstract description 7
- 238000010438 heat treatment Methods 0.000 claims abstract description 5
- 238000007599 discharging Methods 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 3
- 230000008569 process Effects 0.000 claims description 14
- 230000008859 change Effects 0.000 claims description 8
- 230000009467 reduction Effects 0.000 claims description 7
- 239000002699 waste material Substances 0.000 claims description 6
- 239000000385 dialysis solution Substances 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 208000002173 dizziness Diseases 0.000 claims description 2
- 238000000108 ultra-filtration Methods 0.000 claims description 2
- 206010012735 Diarrhoea Diseases 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 238000004513 sizing Methods 0.000 claims 1
- 238000009792 diffusion process Methods 0.000 abstract description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 2
- 230000003204 osmotic effect Effects 0.000 abstract 2
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 4
- 240000007651 Rubus glaucus Species 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000011034 Rubus glaucus Nutrition 0.000 description 2
- 235000009122 Rubus idaeus Nutrition 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 238000006424 Flood reaction Methods 0.000 description 1
- 206010016803 Fluid overload Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101100400378 Mus musculus Marveld2 gene Proteins 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011900 installation process Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/166—Heating
Definitions
- the main disadvantage of the described means is the lack of income for the process of reducing the incidence of urea in patients who have a little pain. Therefore, due to an increase in the degree of care of 25, there is a slight deterioration of the pit, which significantly reduces its rate of disruption.
- This method is included in the introduction, operation and subsequent removal of the dialyzed solution from the abdominal area.
- the global volume is 2 liters. There are 5 cycles that can be smoothed from 12 to 24, but there may be more.
- This session is designed for the use of one and the same product, it is possible to change it at the same time as adding to it, but it is not necessary to add to it.
- the dilution of the dilution is controlled by the dialyzed solution.
- the product is heated and exchanged and sterilized by the use of a bactericidal filter.
- the purpose of the ⁇ -desired treatment is to create a method for treating and dialing and explaining the procedure of 20 installation for it. in ⁇ . impairment
- the optimal combination of concentrators involved in dialysis It is easier to eliminate the pain of the patient. reduction of the resulting disease-damage and longer. the compilation of her-dalzhzya ⁇ properties. 5
- This is a task that resolves . That is, a means of treating a patient through dialysis, an interruption of an interdependent communication between them, and and. ⁇ ⁇ .. ⁇ ⁇ réelle ⁇ .
- V- volume of hydration The estimated time of dialysis. .
- One of the options for the method is that a reduction in the quality of the process and a change in the quantity of 10 glitches in it.
- Another option is to determine that there is a decrease in the quality of the environment and a change in the quantity of salt in it.
- the achieved task is also solved by the fact that the installation is for the implementation of the process of transferring to the storage room, which is conveniently maintained.
- Fig. 1 displays a strict system of terms for the transfer of dialyz, which is in accordance with the general agreement.
- Fig. 3 - a delivery for the delivery of a dialyzed solution;
- Fig. 4 - a dose for removing dialyzed solution.
- - 7 The best options for carrying out the work of the below described patented installation are available in the following process. In the beginning. .there is a choice of
- the unit for regular dialysis contains volume I (fig. 2) for purified water with level sensors. (not shown on the drawings), capacity 2 for on-salt. Interest rate and capacity 3 for glucose equivalents, equipped with a CL-5 panel 4,5,6 with control units connected to a unit 1,2,3 after a compartment of 7,8,9 above a connection to a box ⁇ bee ⁇ echeniya nen ⁇ e ⁇ yvn ⁇ s ⁇ i dialysis bl ⁇ i II, 12,13,14 for ⁇ d ⁇ g ⁇ eva, s ⁇ e ⁇ ilizatsii ⁇ as ⁇ v ⁇ a, ⁇ ya ⁇ lya eg ⁇ ⁇ em ⁇ e ⁇ a ⁇ u ⁇ y and -ele ⁇ v ⁇ dya ⁇ s ⁇ i, d ⁇ za ⁇ y0 15 and 16 and removal ⁇ dachi dializi ⁇ uyuscheg ⁇ ⁇ as ⁇ v ⁇ a, vy ⁇ lnennye as elas ⁇ ichny ⁇ ⁇ z ⁇ achyay ⁇ for s
- the installation also has a system 23 (Fig. 1.2) for the dial-in dialysis device, the console 24, the server 25, the remote control 26, it is for the remote Signalization.
- the regulator is connected to the 24th channel.
- BLOCK ## For the control panel for the temperature and unit 14. For the control panel for the installation of the device
- System 23 of the card is disposed of a dialysis device that is connected to the receiver. floods and. removing from dialysis 16 dialysis unit,
- live capacity-33, which is included in the hydrostatic system, installed via an electromagnet valve (there is no inverse flow between charges 15 and 16.
- Particular block 4 can be made in the form of an elec- tric circuit 0 with power amplifiers at the output, after which there is a solution of blocks 7,8,9, and more.
- the installation process is shown on the basis of its function in the "dialysis" mode, as most generally ... by the way.
- the valve On the 5th of the “start”, the valve is turned on 4,5,6 ( ⁇ ) and it is turned off for discharging the discharges from blocks 7 and 8 and the water flow is discharged.
- Block 12 destroys the bacteria, for example, by irradiating. A high degree of the bactericidal waste stream is eliminated by the elimination of the cost of radiation sources, and the elimination of waste and waste. 10 ⁇ The time of filling the capacitance 17 (Fig. 3). Deliver 15 is activated; the circuit breaker 19 and its signal shuts down the task 25 (Fig. 2).
- the system 42 After a short delay, the system 42, outputs 15 and 16, as a result, turn off. dialysis solution from patient 15 passes into the patient’s stomach. and the processed product from the 16th unit is survived into the sewer.
- the rest of the patient from the patient’s stomach is in the canalization ..
- the last meal is fresh.
- a signal is generated that is suitable for the temperature and power supply of the device. All the parameters are safe. For the patient, the product is in good condition for the operation of the receiver. If one of the cameras were to go beyond the limits of the installed options, through the switch 24., block 28 is turned on.
- the production system is available. There is a system 23. In the case of stability, the operating speed is 5 times, for example, it can be used. There is also a noticeable disconnection of the device, that is, the signal from the output of the system 23 through the terminal 24 includes a block 28.
Landscapes
- Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Le présent procédé de dialyse péritonéale, consistant à ménager un flux à diffusion orientée entre la solution de dialyse et le sang du patient du fait de l'existence du gradient osmotique entre eux, est caractérisé par le fait que la molarité osmotique de la solution de dialyse est diminuée à mesure que la concentration en urée dans le sang du patient décroît au cours de la dialyse. Une installation de mise en ÷uvre du procédé comprend des réservoirs (1, 2, 3) d'eau épurée, un sel ainsi que du glucose, des unités (7, 8, 9) de dosage desdits constituants dont les sorties sont reliées, par un joint en T (30), à l'admission d'une unité (12) de stérilisation de la solution. Des unités (13, 14) de régulation de la température et de la conductivité électrique de la solution sont situées au niveau de la sortie d'une unité de dosage (15) destinée à son alimentation et reliée à une unité (10) assurant la continuité de la dialyse. Une unité de chauffage (11) est montée à l'intérieur du réservoir (1) et elle est dotée d'une unité de régulation (29) de température. Des unités de dosage (15 et 16) destinées à acheminer et à décharger la solution de dialyse se composent de réservoirs transparents (17 et 18), montés chacun sur une plaque fixe (34, 35) dans laquelle est incorporé un premier interrupteur de fin de course (20, 22) et dans la paroi supérieure de laquelle est monté un capteur (36, 37). Elles se composent également de plaques mobiles (38 et 39) situées chacune au-dessus des réservoirs (17, 18) et dotées d'un second interrupteur de fin de course incorporé (19, 21), les interrupteurs de fin de course (19 à 22) ainsi que les capteurs (36, 37) étant montés coaxialement, un réservoir de simulation supplémentaire (33) étant monté entre l'unité de dosage (15) et l'unité de dosage (16). La commande de l'installation s'effectue au moyen d'un pupitre de commande (26), avec une unité (27) de dialyse et une programmation de lavage au formol, par l'intermédiaire d'une unité de commande (24) dotée d'un appareil de réglage (25) et reliée à un système de commande (23) de décharge de solution de dialyse comprenant un indicateur (31) de qualité de dialyse ainsi qu'une unité (32) d'enregistrement du temps de remplissage et de déchargement de la solution; et avec les interrupteurs de fin de course ainsi que la vanne électromagnétique du réservoir supplémentaire de simulation (33).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU4937720 | 1991-04-23 | ||
| SU914937720A RU2001638C1 (ru) | 1991-04-23 | 1991-04-23 | Способ проведени перитонеального диализа |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1992018048A1 true WO1992018048A1 (fr) | 1992-10-29 |
Family
ID=21575294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/RU1992/000080 WO1992018048A1 (fr) | 1991-04-23 | 1992-04-17 | Procede et installation de dialyse peritoneale |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2000692A (fr) |
| RU (1) | RU2001638C1 (fr) |
| WO (1) | WO1992018048A1 (fr) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8870811B2 (en) * | 2006-08-31 | 2014-10-28 | Fresenius Medical Care Holdings, Inc. | Peritoneal dialysis systems and related methods |
| US10363352B2 (en) | 2002-07-19 | 2019-07-30 | Baxter International Inc. | Disposable set and system for dialysis |
| US10646634B2 (en) | 2008-07-09 | 2020-05-12 | Baxter International Inc. | Dialysis system and disposable set |
| US10716886B2 (en) | 2016-05-06 | 2020-07-21 | Gambro Lundia Ab | Systems and methods for peritoneal dialysis having point of use dialysis fluid preparation including testing thereof |
| US11135345B2 (en) | 2017-05-10 | 2021-10-05 | Fresenius Medical Care Holdings, Inc. | On demand dialysate mixing using concentrates |
| US11311657B2 (en) | 2007-07-05 | 2022-04-26 | Baxter International Inc. | Dialysis system for mixing treatment fluid at time of use |
| US11439736B2 (en) | 2008-07-25 | 2022-09-13 | Baxter International Inc. | Dialysis system with online dialysis fluid generation |
| US11495334B2 (en) | 2015-06-25 | 2022-11-08 | Gambro Lundia Ab | Medical device system and method having a distributed database |
| US11504458B2 (en) | 2018-10-17 | 2022-11-22 | Fresenius Medical Care Holdings, Inc. | Ultrasonic authentication for dialysis |
| US11516183B2 (en) | 2016-12-21 | 2022-11-29 | Gambro Lundia Ab | Medical device system including information technology infrastructure having secure cluster domain supporting external domain |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0153164A2 (fr) * | 1984-02-18 | 1985-08-28 | M.L. Laboratories Plc | Solution pour la dialyse péritonéale |
| EP0171834A2 (fr) * | 1981-06-05 | 1986-02-19 | POPOVICH, Robert P. | L'appareil d'irradiation ultraviolette de l'appareil de dialyse |
| US4618343A (en) * | 1983-09-15 | 1986-10-21 | Fresenius Ag | Apparatus for peritoneal dialysis |
| EP0243547A1 (fr) * | 1986-05-01 | 1987-11-04 | Alan M. Peabody | Dispositif de dialyse péritonéale à flux continu |
| SU1593660A1 (ru) * | 1987-10-30 | 1990-09-23 | Научно-Исследовательский Институт Трансплантологии И Искусственных Органов | Устройство дл перитонеального диализа |
| SU1659058A1 (ru) * | 1988-11-18 | 1991-06-30 | Московский областной научно-исследовательский клинический институт им.М.Ф.Владимирского | Способ детоксикации организма |
-
1991
- 1991-04-23 RU SU914937720A patent/RU2001638C1/ru active
-
1992
- 1992-04-17 AU AU20006/92A patent/AU2000692A/en not_active Abandoned
- 1992-04-17 WO PCT/RU1992/000080 patent/WO1992018048A1/fr unknown
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0171834A2 (fr) * | 1981-06-05 | 1986-02-19 | POPOVICH, Robert P. | L'appareil d'irradiation ultraviolette de l'appareil de dialyse |
| US4618343A (en) * | 1983-09-15 | 1986-10-21 | Fresenius Ag | Apparatus for peritoneal dialysis |
| EP0153164A2 (fr) * | 1984-02-18 | 1985-08-28 | M.L. Laboratories Plc | Solution pour la dialyse péritonéale |
| EP0243547A1 (fr) * | 1986-05-01 | 1987-11-04 | Alan M. Peabody | Dispositif de dialyse péritonéale à flux continu |
| SU1593660A1 (ru) * | 1987-10-30 | 1990-09-23 | Научно-Исследовательский Институт Трансплантологии И Искусственных Органов | Устройство дл перитонеального диализа |
| SU1659058A1 (ru) * | 1988-11-18 | 1991-06-30 | Московский областной научно-исследовательский клинический институт им.М.Ф.Владимирского | Способ детоксикации организма |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10363352B2 (en) | 2002-07-19 | 2019-07-30 | Baxter International Inc. | Disposable set and system for dialysis |
| US11235094B2 (en) | 2002-07-19 | 2022-02-01 | Baxter International Inc. | System for peritoneal dialysis |
| US8870811B2 (en) * | 2006-08-31 | 2014-10-28 | Fresenius Medical Care Holdings, Inc. | Peritoneal dialysis systems and related methods |
| US11931497B2 (en) | 2007-07-05 | 2024-03-19 | Baxter International Inc. | System and method for preparing peritoneal dialysis fluid at the time of use |
| US11311657B2 (en) | 2007-07-05 | 2022-04-26 | Baxter International Inc. | Dialysis system for mixing treatment fluid at time of use |
| US10646634B2 (en) | 2008-07-09 | 2020-05-12 | Baxter International Inc. | Dialysis system and disposable set |
| US11918721B2 (en) | 2008-07-09 | 2024-03-05 | Baxter International Inc. | Dialysis system having adaptive prescription management |
| US11311658B2 (en) | 2008-07-09 | 2022-04-26 | Baxter International Inc. | Dialysis system having adaptive prescription generation |
| US11439736B2 (en) | 2008-07-25 | 2022-09-13 | Baxter International Inc. | Dialysis system with online dialysis fluid generation |
| US11495334B2 (en) | 2015-06-25 | 2022-11-08 | Gambro Lundia Ab | Medical device system and method having a distributed database |
| US10828412B2 (en) | 2016-05-06 | 2020-11-10 | Gambro Lundia Ab | Systems and methods for peritoneal dialysis having point of use dialysis fluid preparation including mixing and heating therefore |
| US11718546B2 (en) | 2016-05-06 | 2023-08-08 | Baxter International Inc. | System and a method for producing microbiologically controlled fluid |
| US11045596B2 (en) | 2016-05-06 | 2021-06-29 | Gambro Lundia Ab | Systems and methods for peritoneal dialysis having point of use dialysis fluid preparation using water accumulator and disposable set |
| US10716886B2 (en) | 2016-05-06 | 2020-07-21 | Gambro Lundia Ab | Systems and methods for peritoneal dialysis having point of use dialysis fluid preparation including testing thereof |
| US11939251B2 (en) | 2016-05-06 | 2024-03-26 | Gambro Lundia Ab | Systems and methods for peritoneal dialysis having point of use dialysis fluid preparation including mixing and heating therefore |
| US11516183B2 (en) | 2016-12-21 | 2022-11-29 | Gambro Lundia Ab | Medical device system including information technology infrastructure having secure cluster domain supporting external domain |
| US11135345B2 (en) | 2017-05-10 | 2021-10-05 | Fresenius Medical Care Holdings, Inc. | On demand dialysate mixing using concentrates |
| US11752246B2 (en) | 2017-05-10 | 2023-09-12 | Fresenius Medical Care Holdings, Inc. | On demand dialysate mixing using concentrates |
| US11504458B2 (en) | 2018-10-17 | 2022-11-22 | Fresenius Medical Care Holdings, Inc. | Ultrasonic authentication for dialysis |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2001638C1 (ru) | 1993-10-30 |
| AU2000692A (en) | 1992-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4338190A (en) | Peritoneal artificial kidney | |
| JP6936267B2 (ja) | 高対流家庭用血液透析／血液濾過および吸着剤システム | |
| CA2686319C (fr) | Dispositif pour une connexion a une source de liquide | |
| CA2233198C (fr) | Procede de test de l'integrite d'un appareil de dialyse avant son utilisation | |
| EP0028371B1 (fr) | Appareil pour dialyse péritonéale automatique et semi-continue | |
| EP3638337B1 (fr) | Appareil de purification d'eau et procédés de nettoyage de l'appareil de purification d'eau | |
| US6758975B2 (en) | Automated peritoneal dialysis system and process with in-line sterilization of dialysate | |
| US3506126A (en) | Closed recirculating hemodialysis system | |
| CN1105582C (zh) | 联接器装置 | |
| JP7145174B2 (ja) | 浄水装置および浄水装置における少なくとも１つの流体特性を制御する方法 | |
| CA1173712A (fr) | Methode et appareil pour la dialyse peritoneale | |
| WO1992018048A1 (fr) | Procede et installation de dialyse peritoneale | |
| JP2003235961A (ja) | モジュラー型在宅透析システム | |
| JP2007510473A5 (fr) | ||
| US12070539B2 (en) | Extracorporeal blood treatment method | |
| JP2000126767A (ja) | 精製水の製造方法および装置 | |
| JP3378057B2 (ja) | 人工透析器の透析液流路の殺菌洗浄装置 | |
| CN2253204Y (zh) | 人工肾透析液再利用装置 | |
| Shaldona et al. | Three Years of Experience with On-Line Preparation of Sterile Pyrogen-Free | |
| EP4188475A1 (fr) | Systèmes de thérapie d'insuffisance rénale à temps réduit entre traitements | |
| US20240189777A1 (en) | Water purification apparatus and methods for cleaning the water purification apparatus | |
| WO1981000518A1 (fr) | Rein artificlel | |
| RU2031662C1 (ru) | Устройство для перитонеального диализа | |
| JPH0117703B2 (fr) | ||
| JPS5930427B2 (ja) | ホロ−ファイバ型人工腎臓の洗浄方法および装置 |